Literature DB >> 20401483

In vitro biofilm activity of non-Candida albicans Candida species.

Sónia Silva1, Mariana Henriques, Rosário Oliveira, David Williams, Joana Azeredo.   

Abstract

Candidosis has been attributed to C. albicans; however, infections caused by non-Candida albicans Candida (NCAC) species are increasingly being recognised. The ability of Candida to grow as a biofilm is an important feature that promotes both infection and persistence in the host. The biofilms' activity is significant since high activity might be associated with enhanced expression of putative virulence factors, whilst in contrast low activity has previously been suggested as a mechanism for resistance of biofilm cells to antimicrobials. The aim of this study was to determine the metabolic activity of in vitro biofilms formed by different clinical isolates of NCAC species. The in situ total metabolic activity of C. parapsilosis, C. tropicalis and C. glabrata biofilms was determined using 2,3-(2-methoxy-4-nitro-5-sulphophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide (XTT) reduction assay, and the number of cultivable cells was also established by CFU (colony forming unit) counts. The biofilm structure was assessed by scanning electron microscopy (SEM). Results showed that total biofilm metabolic activity was species and strain dependent. C. glabrata exhibited the lowest biofilm metabolic activity despite having the highest number of biofilm cultivable cells. Similarly, the metabolic activity of resuspended C. glabrata biofilm and planktonic cells was lower than that of the other species. This study demonstrates the existence of intrinsic activity differences amongst NCAC species, which could have important implications in terms of species relative virulence. Furthermore, the absence of an obvious correlation, between cultivable cells number and total biofilm activity, raises the question about which parameter is the most appropriate for the in vitro assessment of biofilms and their potential clinical significance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20401483     DOI: 10.1007/s00284-010-9649-7

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  27 in total

1.  Role of dimorphism in the development of Candida albicans biofilms.

Authors:  George S Baillie; L Julia Douglas
Journal:  J Med Microbiol       Date:  1999-07       Impact factor: 2.472

2.  Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Authors:  J Chandra; D M Kuhn; P K Mukherjee; L L Hoyer; T McCormick; M A Ghannoum
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

3.  Candida albicans and Candida dubliniensis: comparison of biofilm formation in terms of biomass and activity.

Authors:  M Henriques; J Azeredo; R Oliveira
Journal:  Br J Biomed Sci       Date:  2006       Impact factor: 3.829

Review 4.  Fungal infections associated with HIV infection.

Authors:  L P Samaranayake; P L Fidel; J R Naglik; S P Sweet; R Teanpaisan; M M Coogan; E Blignaut; P Wanzala
Journal:  Oral Dis       Date:  2002       Impact factor: 3.511

Review 5.  Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.

Authors:  P L Fidel; J A Vazquez; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

6.  Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis.

Authors:  A L Colombo; J Perfect; M DiNubile; K Bartizal; M Motyl; P Hicks; R Lupinacci; C Sable; N Kartsonis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-07-23       Impact factor: 3.267

7.  Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.

Authors:  Pranab K Mukherjee; Jyotsna Chandra; Duncan M Kuhn; Mahmoud A Ghannoum
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  Uses and limitations of the XTT assay in studies of Candida growth and metabolism.

Authors:  D M Kuhn; M Balkis; J Chandra; P K Mukherjee; M A Ghannoum
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

Review 9.  Pathogenesis of Candida infections.

Authors:  F C Odds
Journal:  J Am Acad Dermatol       Date:  1994-09       Impact factor: 11.527

10.  Identification of Candida species by PCR and restriction fragment length polymorphism analysis of intergenic spacer regions of ribosomal DNA.

Authors:  D W Williams; M J Wilson; M A Lewis; A J Potts
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

View more
  27 in total

1.  Assessment and Optimizations of Candida albicans In Vitro Biofilm Assays.

Authors:  Matthew B Lohse; Megha Gulati; Ashley Valle Arevalo; Adam Fishburn; Alexander D Johnson; Clarissa J Nobile
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 2.  Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment.

Authors:  Natália Martins; Isabel C F R Ferreira; Lillian Barros; Sónia Silva; Mariana Henriques
Journal:  Mycopathologia       Date:  2014-05-01       Impact factor: 2.574

3.  In vitro Paracoccidioides brasiliensis biofilm and gene expression of adhesins and hydrolytic enzymes.

Authors:  Janaina de Cássia Orlandi Sardi; Nayla de Souza Pitangui; Aline Raquel Voltan; Jaqueline Derissi Braz; Marcelo Pelajo Machado; Ana Marisa Fusco Almeida; Maria Jose Soares Mendes Giannini
Journal:  Virulence       Date:  2015       Impact factor: 5.882

4.  Candida albicans and non-C. albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections.

Authors:  A V Ferreira; C G Prado; R R Carvalho; K S T Dias; A L T Dias
Journal:  Mycopathologia       Date:  2013-03-27       Impact factor: 2.574

5.  Candida tropicalis Biofilms: Biomass, Metabolic Activity and Secreted Aspartyl Proteinase Production.

Authors:  Melyssa Negri; Sónia Silva; Isis Regina Grenier Capoci; Joana Azeredo; Mariana Henriques
Journal:  Mycopathologia       Date:  2015-11-16       Impact factor: 2.574

6.  Dynamics of Mixed- Candida Species Biofilms in Response to Antifungals.

Authors:  G Vipulanandan; M Herrera; N P Wiederhold; X Li; J Mintz; B L Wickes; D Kadosh
Journal:  J Dent Res       Date:  2017-08-29       Impact factor: 6.116

7.  Effect of Voriconazole on Candida tropicalis Biofilms: Relation with ERG Genes Expression.

Authors:  Tânia Fernandes; Sónia Silva; Mariana Henriques
Journal:  Mycopathologia       Date:  2016-06-03       Impact factor: 2.574

Review 8.  Candida glabrata: a review of its features and resistance.

Authors:  C F Rodrigues; S Silva; M Henriques
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-19       Impact factor: 3.267

9.  Pathogenesis and treatment of oral candidosis.

Authors:  David Williams; Michael Lewis
Journal:  J Oral Microbiol       Date:  2011-01-28       Impact factor: 5.474

10.  Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates.

Authors:  Juliana C Junqueira; Beth B Fuchs; Maged Muhammed; Jeffrey J Coleman; Jamal M A H Suleiman; Simone F G Vilela; Anna C B P Costa; Vanessa M C Rasteiro; Antonio O C Jorge; Eleftherios Mylonakis
Journal:  BMC Microbiol       Date:  2011-11-04       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.